
Michael Lee
Examiner (ID: 12147, Phone: (571)272-7349 , Office: P/2422 )
| Most Active Art Unit | 2422 |
| Art Unit(s) | 2622, 2422, 2714, 2614, 2711, 1661, 2602 |
| Total Applications | 3017 |
| Issued Applications | 2434 |
| Pending Applications | 176 |
| Abandoned Applications | 432 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11704447
[patent_doc_number] => 20170172945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'METHODS OF TREATING BREAST CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/300659
[patent_app_country] => US
[patent_app_date] => 2015-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11770
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15300659
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/300659 | METHODS OF TREATING BREAST CANCER | Mar 31, 2015 | Abandoned |
Array
(
[id] => 10373108
[patent_doc_number] => 20150258114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-17
[patent_title] => 'METHODS FOR ACUTE AND LONG-TERM TREATMENT OF SUBSTANCE ABUSE USING IBOGAINE'
[patent_app_type] => utility
[patent_app_number] => 14/635934
[patent_app_country] => US
[patent_app_date] => 2015-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20543
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14635934
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/635934 | METHODS FOR ACUTE AND LONG-TERM TREATMENT OF SUBSTANCE ABUSE USING IBOGAINE | Mar 1, 2015 | Abandoned |
Array
(
[id] => 10361050
[patent_doc_number] => 20150246055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-03
[patent_title] => 'METHODS FOR ACUTE AND LONG-TERM TREATMENT OF OPIOID AND OPIOID-LIKE DRUG ADDICTION'
[patent_app_type] => utility
[patent_app_number] => 14/635842
[patent_app_country] => US
[patent_app_date] => 2015-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18650
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14635842
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/635842 | METHODS FOR ACUTE AND LONG-TERM TREATMENT OF OPIOID AND OPIOID-LIKE DRUG ADDICTION | Mar 1, 2015 | Abandoned |
Array
(
[id] => 10373105
[patent_doc_number] => 20150258111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-17
[patent_title] => 'METHODS AND COMPOSITIONS FOR REDUCING TOLERANCE TO OPIOID ANALGESICS USING IBOGAINE AND DERIVATIVES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/635871
[patent_app_country] => US
[patent_app_date] => 2015-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11964
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14635871
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/635871 | METHODS AND COMPOSITIONS FOR REDUCING TOLERANCE TO OPIOID ANALGESICS USING IBOGAINE AND DERIVATIVES THEREOF | Mar 1, 2015 | Abandoned |
Array
(
[id] => 10373054
[patent_doc_number] => 20150258061
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-17
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATMENT OF NEURODEGENERATIVE DISEASE'
[patent_app_type] => utility
[patent_app_number] => 14/626524
[patent_app_country] => US
[patent_app_date] => 2015-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10483
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14626524
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/626524 | Compositions and methods for treatment of neurodegenerative disease | Feb 18, 2015 | Issued |
Array
(
[id] => 11581725
[patent_doc_number] => 09636345
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-02
[patent_title] => 'Benzimidazole derivatives useful TRPM8 channel modulators'
[patent_app_type] => utility
[patent_app_number] => 14/618462
[patent_app_country] => US
[patent_app_date] => 2015-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13930
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14618462
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/618462 | Benzimidazole derivatives useful TRPM8 channel modulators | Feb 9, 2015 | Issued |
Array
(
[id] => 10265867
[patent_doc_number] => 20150150865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-04
[patent_title] => 'COMBINATION DRUG FOR TREATING VASCULAR DISORDER'
[patent_app_type] => utility
[patent_app_number] => 14/616569
[patent_app_country] => US
[patent_app_date] => 2015-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4426
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14616569
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/616569 | COMBINATION DRUG FOR TREATING VASCULAR DISORDER | Feb 5, 2015 | |
Array
(
[id] => 11574588
[patent_doc_number] => 09629829
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-04-25
[patent_title] => 'Methods of treating hepatic encephalopathy'
[patent_app_type] => utility
[patent_app_number] => 14/612697
[patent_app_country] => US
[patent_app_date] => 2015-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 25451
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14612697
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/612697 | Methods of treating hepatic encephalopathy | Feb 2, 2015 | Issued |
Array
(
[id] => 10248516
[patent_doc_number] => 20150133513
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-14
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF PARKINSONS DISEASE'
[patent_app_type] => utility
[patent_app_number] => 14/602518
[patent_app_country] => US
[patent_app_date] => 2015-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6356
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14602518
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/602518 | Pharmaceutical compositions for treatment of Parkinson's disease | Jan 21, 2015 | Issued |
Array
(
[id] => 10289090
[patent_doc_number] => 20150174088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-25
[patent_title] => 'FOOD SUPPLEMENT CONTAINING ALPHA-KETO ACIDS FOR SUPPORTING DIABETES THERAPY'
[patent_app_type] => utility
[patent_app_number] => 14/582571
[patent_app_country] => US
[patent_app_date] => 2014-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4687
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14582571
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/582571 | FOOD SUPPLEMENT CONTAINING ALPHA-KETO ACIDS FOR SUPPORTING DIABETES THERAPY | Dec 23, 2014 | Abandoned |
Array
(
[id] => 10220359
[patent_doc_number] => 20150105352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-16
[patent_title] => 'COMBINATION OF AN HMG-COA REDUCTASE INHIBITOR AND A FARNESYL-PYROPHOSPHATASE SYNTHASE INHIBITOR FOR THE TREATMENT OF DISEASES RELATED TO THE PERSISTENCE AND/OR ACCUMULATION OF PRENYLATED PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 14/575814
[patent_app_country] => US
[patent_app_date] => 2014-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9757
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14575814
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/575814 | COMBINATION OF AN HMG-COA REDUCTASE INHIBITOR AND A FARNESYL-PYROPHOSPHATASE SYNTHASE INHIBITOR FOR THE TREATMENT OF DISEASES RELATED TO THE PERSISTENCE AND/OR ACCUMULATION OF PRENYLATED PROTEINS | Dec 17, 2014 | Abandoned |
Array
(
[id] => 11129190
[patent_doc_number] => 20160326165
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-10
[patent_title] => 'ALKOXYCARBONYL HEMIACETAL-TYPE ESTER PRODRUG OF PYRIDONE CARBOXYLIC ACID ANTIBACTERIAL DRUG'
[patent_app_type] => utility
[patent_app_number] => 15/108506
[patent_app_country] => US
[patent_app_date] => 2014-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17307
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15108506
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/108506 | ALKOXYCARBONYL HEMIACETAL-TYPE ESTER PRODRUG OF PYRIDONE CARBOXYLIC ACID ANTIBACTERIAL DRUG | Dec 17, 2014 | Abandoned |
Array
(
[id] => 13265313
[patent_doc_number] => 10144731
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-04
[patent_title] => Nrf2 regulators
[patent_app_type] => utility
[patent_app_number] => 15/105306
[patent_app_country] => US
[patent_app_date] => 2014-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 112719
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15105306
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/105306 | Nrf2 regulators | Dec 16, 2014 | Issued |
Array
(
[id] => 10209292
[patent_doc_number] => 20150094283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-02
[patent_title] => 'COMBINATION'
[patent_app_type] => utility
[patent_app_number] => 14/565691
[patent_app_country] => US
[patent_app_date] => 2014-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15246
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14565691
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/565691 | COMBINATION | Dec 9, 2014 | Abandoned |
Array
(
[id] => 10297631
[patent_doc_number] => 20150182630
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-02
[patent_title] => 'HYDROGEL COMPOSITION FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 14/541784
[patent_app_country] => US
[patent_app_date] => 2014-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 1413
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14541784
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/541784 | Hydrogel composition for the treatment of dermatological disorders | Nov 13, 2014 | Issued |
Array
(
[id] => 10782821
[patent_doc_number] => 20160128977
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2016-05-12
[patent_title] => 'STABILIZED STATIN FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 14/538464
[patent_app_country] => US
[patent_app_date] => 2014-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8250
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14538464
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/538464 | Stabilized statin formulations | Nov 10, 2014 | Issued |
Array
(
[id] => 10782821
[patent_doc_number] => 20160128977
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2016-05-12
[patent_title] => 'STABILIZED STATIN FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 14/538464
[patent_app_country] => US
[patent_app_date] => 2014-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8250
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14538464
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/538464 | Stabilized statin formulations | Nov 10, 2014 | Issued |
Array
(
[id] => 13013797
[patent_doc_number] => 10030006
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-24
[patent_title] => Coumarin based Hsp90 inhibitors with urea and ether substituents
[patent_app_type] => utility
[patent_app_number] => 15/035610
[patent_app_country] => US
[patent_app_date] => 2014-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 26751
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15035610
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/035610 | Coumarin based Hsp90 inhibitors with urea and ether substituents | Nov 10, 2014 | Issued |
Array
(
[id] => 10256418
[patent_doc_number] => 20150141415
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-21
[patent_title] => 'Methionine Aminopeptidase Inhibitors for Treating Infectious Diseases'
[patent_app_type] => utility
[patent_app_number] => 14/536024
[patent_app_country] => US
[patent_app_date] => 2014-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 13323
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14536024
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/536024 | Methionine Aminopeptidase Inhibitors for Treating Infectious Diseases | Nov 6, 2014 | Abandoned |
Array
(
[id] => 11082192
[patent_doc_number] => 20160279155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-29
[patent_title] => 'NOVEL FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 15/035006
[patent_app_country] => US
[patent_app_date] => 2014-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 85525
[patent_no_of_claims] => 87
[patent_no_of_ind_claims] => 66
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15035006
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/035006 | NOVEL FORMULATIONS | Nov 5, 2014 | Abandoned |